Evidence map›Paper›PMID 41328156›Full record

ArticlePatterns (New York, N.Y.)2025

UltraLight VM-UNet: Parallel Vision Mamba significantly reduces parameters for skin lesion segmentation.

Renkai Wu, Yinghao Liu, Guochen Ning, Pengchen Liang, Qing Chang

Abstract read
In one paragraph

Article in Patterns (New York, N.Y.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. ZRFrontiers in bioinformatics · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Renkai WuDepartment of Geriatrics, Medical Center on Aging of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Yinghao LiuSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China.
Guochen NingSchool of Clinical Medicine, Tsinghua University, Beijing 100084, China.
Pengchen LiangSchool of Microelectronics, Shanghai University, Shanghai 201800, China.
Qing ChangDepartment of Geriatrics, Medical Center on Aging of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traditionally, to improve the segmentation performance of models, most approaches prefer to use more complex modules. This is not suitable for the medical field, especially for mobile medical devices, where computationally loaded models are not suitable for real clinical environments due to computational resource constraints. Recently, state-space models, represented by Mamba, have become a strong competitor to traditional convolutional neural networks and transformers. In this paper, we deeply explore the key elements of parameter influence in Mamba and propose an UltraLight Vision Mamba UNet (UltraLight VM-UNet) based on this. Specifically, we propose a method for processing features in parallel Vision Mamba, named the PVM Layer, which achieves competitive performance with the lowest computational complexity while keeping the overall number of processing channels constant. We conducted segmentation experiments on three public datasets of skin lesions and showed that UltraLight VM-UNet exhibits competitive performance with only 0.049M parameters and 0.060 GFLOPs.

Indexed as

lightweight modelMambaskin lesion segmentation

Identifiers

PMID41328156
PMCPMC12664954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.